Search Results for: GNK
A renowned billionaire investor, a French energy giant, and other insiders were scooping up shares of these five stocks as the second quarter began.
Published:
We screened our 24/7 Wall St. dividend equity research database, looking for stocks that pay massive dividends, and we found 22 companies that combined can generate over $3000 a year in passive...
Published:
Last Updated:
We have many stocks moving in the after-hours trading session, and most of the moves are on earnings. 24/7 Wall St. has tracked moves in shares of the following: Concur Technologies Inc. (NASDAQ:...
Published:
Last Updated:
Asian films have come a long way since its inception, evolving over the years into an art form that has gained international recognition. Asian actresses have also expanded and fine-tuned their...
Published:
Earnings season is seeming to wind down here, but that won’t stop the unusual suspects of key equity events and issues to watch this coming week. We are looking into key issues for the coming...
Published:
Last Updated:
GNC Holdings Inc. (NYSE: GNC) is public again. The vitamin and nutrients retailer sold 22.5 million shares at a price of $16.00 per share. This was in the middle of the $15.00 to $17.00 indicated...
Published:
Last Updated:
We have many stocks moving this morning. 24/7 Wall St. has tracked moves in shares of the following: Concur Technologies Inc. (NASDAQ: CNQR), DUSAÂ Pharmaceuticals Inc. (NASDAQ: DUSA), Genomic Health...
Published:
Last Updated:
GlaxoSmithKline (GSK) wants everyone, including the FDA, to know that its diabetes drug Avadia is "safe and effective when used appropriately." Almost everyone else thinks that the drug...
Published:
Genworth Financial Inc. (NYSE: GNW) is still up significantly from its post-crash lows. Unfortunately, that is where the good news stops. Last week, we identified life insurance companies who...
Published:
Last Updated:
The U.S. Centers for Medicare & Medicaid Services issued its final ruling governing use of a class of anemia drugs including Amgen’s (AMGN) Aranesp .The CMOS guided doctors to restrict the...
Published:
After bad-mouthing research attacking its diabetes drug Avandia, word now comes from The New York Times that GlaxoSmithKline (GSK) attempted to intimidate a well-known diabetes researcher, Dr. John...
Published:
On Friday, ChemoCentryx Inc. filed to withdraw its pending registration for an IPO of up to $57.5 million. The market conditions of today are cited as the reasoning. The Mountain View,...
Published:
Last Updated:
Source: ThinkstockA recovery of the overall German economy has been questioned, based on negative data from Eurostat and Markit. New information from GfK states that Germany has not only recovered...
Published:
GlaxoSmithKline (GSK) thinks that it is being beat up on in the press. And now Congress is looking into whether the FDA has been aggressive enough in warning consumers about the risks of drugs like...
Published: